These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 39139662)
1. Point-of-care Testing HbA1c screening for type 2 diabetes in urban and rural areas of China: a cost-effectiveness analysis. Shao Q; Xie X; Wang L; Gao L; Hu Y; Zhang Y Front Public Health; 2024; 12():1438945. PubMed ID: 39139662 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study. Zhang Y; Sun J; Pang Z; Gao W; Sintonen H; Kapur A; Qiao Q Prim Care Diabetes; 2013 Dec; 7(4):275-82. PubMed ID: 24021478 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study. Gillett M; Brennan A; Watson P; Khunti K; Davies M; Mostafa S; Gray LJ Health Technol Assess; 2015 May; 19(33):1-80. PubMed ID: 25947106 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification. Ohde S; Moriwaki K; Takahashi O BMC Endocr Disord; 2021 May; 21(1):105. PubMed ID: 34022872 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a New Opportunistic Screening Strategy for Walk-in Fingertip HbA Shono A; Kondo M; Hoshi SL; Okubo R; Yahagi N Diabetes Care; 2018 Jun; 41(6):1218-1226. PubMed ID: 29686159 [TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis. Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141 [TBL] [Abstract][Full Text] [Related]
7. Fasting capillary blood glucose: an appropriate measurement in screening for diabetes and pre-diabetes in low-resource rural settings. Zhao X; Zhao W; Zhang H; Li J; Shu Y; Li S; Cai L; Zhou J; Li Y; Hu R J Endocrinol Invest; 2013 Jan; 36(1):33-7. PubMed ID: 22453076 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model. Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984 [TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Three Doses of a Behavioral Intervention to Prevent or Delay Type 2 Diabetes in Rural Areas. Radcliff TA; Côté MJ; Whittington MD; Daniels MJ; Bobroff LB; Janicke DM; Perri MG J Acad Nutr Diet; 2020 Jul; 120(7):1163-1171. PubMed ID: 31899170 [TBL] [Abstract][Full Text] [Related]
10. Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country. Muktabhant B; Sanchaisuriya P; Sarakarn P; Tawityanon W; Trakulwong M; Worawat S; Schelp FP BMC Public Health; 2012 May; 12():349. PubMed ID: 22583817 [TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment]. Zhao FH; Chen JF; Gao XH; Gao LM; Liu QG; Liu ZH; Xu H; Ma JF; Ma L; Xu XL; Hu SY; Ning Y; Shi JF; Qiao YL Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):632-6. PubMed ID: 23159002 [TBL] [Abstract][Full Text] [Related]
12. Comparing the effectiveness and cost-effectiveness of alternative type 2 diabetes monitoring intervals in resource limited settings. Mukonda E; Lesosky M; Sithole S; van der Westhuizen DJ; Rusch JA; Levitt NS; Myers B; Cleary S Health Policy Plan; 2024 Oct; 39(9):946-955. PubMed ID: 39096519 [TBL] [Abstract][Full Text] [Related]
13. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program. Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model. Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and cost-effectiveness of six GLP-1RAs for treatment of Chinese type 2 diabetes mellitus patients that inadequately controlled on metformin: a micro-simulation model. Yuan S; Wu Y Front Public Health; 2023; 11():1201818. PubMed ID: 37744474 [TBL] [Abstract][Full Text] [Related]
16. Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis. El-Osta A; Woringer M; Pizzo E; Verhoef T; Dickie C; Ni MZ; Huddy JR; Soljak M; Hanna GB; Majeed A BMJ Open; 2017 Aug; 7(8):e015494. PubMed ID: 28814583 [TBL] [Abstract][Full Text] [Related]
17. Variation in Point-of-Care Testing of HbA1c in Diabetes Care in General Practice. Kristensen T; Waldorff FB; Nexøe J; Skovsgaard CV; Olsen KR Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29120361 [No Abstract] [Full Text] [Related]
18. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data. Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353 [TBL] [Abstract][Full Text] [Related]
19. Point-of-care testing improves diabetes management in a primary care clinic in South Africa. Motta LA; Shephard MDS; Brink J; Lawson S; Rheeder P Prim Care Diabetes; 2017 Jun; 11(3):248-253. PubMed ID: 28161128 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]